Michele Rhee
Vice President - Global Advocacy Relations & Patient Engagement Savara Pharmaceuticals
Seminars
Thursday 26th March 2026
Rare & Ultra-Rare Diseases: Designing Programs for Maximum Patient Impact
4:15 pm
- Navigating patient advocacy pressures, ethical considerations, and access equity
- Supporting single-patient vs cohort access in a dynamic regulatory environment
- Applying concrete program design and operational solutions for rare and ultra-rare diseases
